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Key points
 Tenascin-X (TNX) is an extracellular matrix glycoprotein with anti-adhesive properties in skin
and joints. Here we report the novel finding that TNX is expressed in human and mouse gut
tissue where it is exclusive to specific subpopulations of neurones.
 Our studies with TNX-deficient mice show impaired defecation and neural control of distal
colonic motility that can be rescued with a 5-HT4 receptor agonist. However, colonic secretion
is unchanged. They are also susceptible to internal rectal intussusception. Colonic afferent
sensitivity is increased in TNX-deficient mice. Correspondingly, there is increased density of
and sensitivity of putative nociceptive fibres in TNX-deficient mucosa.
 A group of TNX-deficient patients report symptoms highly consistent with those in the mouse
model.
 These findings suggest TNX plays entirely different roles in gut to non-visceral tissues – firstly
a role in enteric motor neurones and secondly a role influencing nociceptive sensory neurones
 Studying further the mechanisms by which TNX influences neuronal function will lead to new
targets for future treatment.
Abstract The extracellular matrix (ECM) is not only an integral structural molecule, but is also
critical for a wide range of cellular functions. The glycoprotein tenascin-X (TNX) predominates
in the ECM of tissues like skin and regulates tissue structure through anti-adhesive interactions
with collagen. Monogenic TNX deficiency causes painful joint hypermobility and skin hyper-
elasticity, symptoms characteristic of hypermobility Ehlers Danlos syndrome (hEDS). hEDS
patients also report consistently increased visceral pain and gastrointestinal (GI) dysfunction.
Rubina Aktar completed her PhD in 2016 and is currently working as a Post-Doctoral Research Fellow at the Wingate Institute of
Neurogastroenterology. Her research interests encompass the normal and disease-mediated function of enteric neurons. Her PhD
topic centred on the role of extracellular matrix molecule tenascin-X and how it affects gut function. Specifically, she is studying
the cellular/molecular mechanisms underlying connective tissue defects in gut function. The motivation to study this area is based
on an increased prevalence of gastrointestinal symptoms in patients with connective tissue abnormality such as the hypermobile
Ehlers-Danlos group. Gut symptoms in this cohort of patients are parallel to symptoms in patients with irritable bowel syndrome and
functional gut disorders. Furthermore, she has been involved in and has a keen interest in understanding visceral pain mechanisms,
the role of microbiota in gut function and how nutrients and food affect appetite.
∗Joint senior authors.
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We investigated whether there is a direct link between TNX deficiency and GI pain or motor
dysfunction. We set out first to learn where TNX is expressed in human and mouse, then
determine how GI function, specifically in the colon, is disordered in TNX-deficient mice and
humans of either sex. In human and mouse tissue, TNX was predominantly associated with
cholinergic colonic enteric neurones, which are involved in motor control. TNX was absent
from extrinsic nociceptive peptidergic neurones. TNX-deficient mice had internal rectal prolapse
and a loss of distal colonic contractility which could be rescued by prokinetic drug treatment.
TNX-deficient patients reported increased sensory andmotor GI symptoms including abdominal
pain and constipation compared to controls. Despite absence of TNX from nociceptive colonic
neurones, neuronal sprouting and hyper-responsiveness to colonic distension was observed in
the TNX-deficient mice. We conclude that ECMmolecules are not merely support structures but
an integral part of the microenvironment particularly for specific populations of colonic motor
neurones where TNX exerts functional influences.
(Resubmitted 12 April 2018; accepted after revision 11 June 2018; first published online 19 June 2018)
Corresponding author L. A. Blackshaw: Wingate Institute, 26 Ashfield Street, London E1 2AJ,
UK. Email: a.blackshaw@qmul.ac.uk
Introduction
The extracellular matrix (ECM) provides a basic
intercellular scaffold critical in tissue development,
differentiation, signalling and homeostasis. The ECM
comprises macromolecules including the glycoprotein
tenascin-X (TNX) (Zweers et al. 2003).TNXcontributes to
ECMaround connective tissueswithin skin/joints through
anti-adhesive interactions with collagen (Valcourt et al.
2015). Monogenic TNX deficiency causes hypermobility
of skin including tissue fragility and musculoskeletal
pain, a phenotype similar to hypermobile Ehlers-Danlos
syndrome (hEDS) (Burch et al. 1997; Hakim & Grahame,
2003). Interestingly there is a high (39%) representation
of hEDS amongst patients with functional gastro-
intestinal (GI) disorders (FGIDs) (Fikree et al. 2015). A
recent study in classical, vascular and hypermobile EDS
showed 56% of patients had GI manifestations (Nelson
et al. 2015). Common symptoms were abdominal pain
(56.1%), nausea (44.3%), constipation (42.4%) and FGID
symptoms (39%) with symptom severity correlating with
more severe hEDS phenotype (Fikree et al. 2014). Physio-
logical studies demonstrate hEDS patients have colonic
dysmotility, with 28.3% of hEDS patients exhibiting
delayed colonic transit (Nelson et al. 2015). However, the
mechanismsunderlying changes to colonic transit inhEDS
are unknown.
Recently, TNXdeficiency has been classified as a distinct
subgroup (classical-like EDS) within the EDS spectrum
disorders (Malfait et al. 2017) and GI manifestations
are particularly common in these patients. For instance,
case studies inTNX-deficient patients report constipation,
rectal prolapse, abdominal pain, diverticulosis and hiatal
hernia (Schalkwijk et al. 2001; Lindor & Bristow,
2005). However, the cellular mechanisms mediating GI
symptoms are yet to be described. TNX-deficient mice
show musculoskeletal and cutaneous features of hEDS
(Mao et al. 2002) while other aspects of physiology remain
uninvestigated.
Given that hindgut symptoms are common in hEDS
and TNX-deficient patients, we hypothesized that TNX is
needed for sensorimotor function of the colon.Our search
for a mechanistic link required an understanding of both
anatomical expression and the functional role of TNX
in the colon. We characterized colocalization of TNX in
mouse and human gut with neuronal markers. To under-
stand the functional role of TNX, it was important to
perform detailed assessment of colon function. Colonic
function requires the integration of multiple complex
pathways including coordinated action of enteric neurons
and smooth muscle cells, and input from external
sources (Sarna, 1993). These influence myogenic and
enteric neuronal regulation to modify gut contractions in
response to the environment (Sarna, 2010). To assess the
overall role of TNX in the colonwe studied: gross anatomy
and defecatory function (Page et al. 2004); colonic motor
coordination in vitro (Fraser et al. 1997); activity of colonic
splanchnic nerves using in vitro afferent electrophysiology
(Hockley et al. 2017); and the ability of the colonic
epithelium to secrete ions in vitro (Cox et al. 2001). Finally,
we assessedGI symptoms in patients with TNXdeficiency.
We show in both mouse and human gut that TNX
expression is associated not with connective tissue, but
with enteric neurones. In the genetically confirmed
TNX-deficient patients, we assessed if GI symptoms are
similar to those reported in case studies, and in the
hEDS subgroup (Demirdas et al. 2016). To understand
the mechanistic role of TNX, we used a knockout mouse
(Mao et al. 2002). Protein expression and the functional
role of TNX in the GI tract have not been investigated
previously, except one study showing mRNA expression
in porcine stomach and colon (Geffrotin et al. 1995).
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We provide evidence for the first time that an
ECM molecule – TNX – has a role in colonic
function. Gut function is disrupted by the increased
incidence of prolapse in TNX-deficient mice and humans.
Colonic motility is attenuated, particularly in the distal
segment, which is reversible pharmacologically. Colonic
nociceptive afferents are hypersensitive in the absence
of TNX, and there is increased sensory neuronal
sprouting. The expression and functional outcomes in
the TNX-deficient mouse match closely the reported
symptoms in TNX-deficient patients. Based on the
expression, functional and patient symptom data we
provide a role for TNX in maintaining normal colonic
function.Overall, our studies have important implications
for understanding the role and exact mechanism of how
ECM components influence gut function in health and
disease.
Methods
Ethical approval
Full-thickness non-pathological colonic tissue was
obtained from cancer patients (>10 cm away from
tumours) undergoing colonic resections using approved
Human Research Ethics from Bart’s and London NHS
Trust with informed consent (NREC 09/H0704/2).
TNX-deficient patients gave written informed consent
prior to completing the questionnaires.
All studies were completed according to the animal
ethics policy and the study is in compliancewith guidelines
set out by Grundy (2015). All mice used in these studies
were killed by asphyxiation using carbon dioxide in
accordancewith theUKHomeOffice (Schedule1,Animals
Act 1986) for all experimental procedures. All human
questionnaire studies were completed in accordance with
the Declaration of Helsinki.
Mouse tissue
All mice used in this study originated from parent mice
with a C57BL/6N background and were donated by
Professor Manuel Koch (University of Cologne). From
this group, TNX-KO was created by targeting the 5′ end
of TNXB gene, replacing the first five coding exons with
lacZ and a neomycin resistance cassette (Mao et al. 2002).
Knockout (KO)andwild-typemice showed similar growth
and were of similar weight at the time of the study (WT:
19.9 ± 0.8 g and KO: 20.8 ± 1.1 g). All mice were reared
and transported under conditions specified in the UK’s
Animal Welfare Act 2006. Mice aged between 10 and 12
weeks were used and were killed by a rising concentration
of CO2 asphyxiation (Schedule 1, Animals Act 1986, UK
Home Office).
Immunohistochemistry
Immunolabelling with rabbit polyclonal TNX (1:200,
Santa Cruz, sc-25717, Santa Cruz, CA, USA), calretinin
(1:500, Swant, CG1 and 6B3, Marly, Switzerland),
calcitonin gene-related peptide (CGRP) (1:400, Abcam,
ab36001, Cambridge, MA, USA; and Thermo Fisher,
ABS026-05-02, Waltham, MA, USA), choline acetyl-
transferase (ChAT) (1:400, Millipore, AB144P, , Billerica,
MA, USA), neuronal nitric oxide synthase (NOS) (1:400,
Abcam, ab1376), protein gene product 9.5 (PGP9.5)
(1:500, Agilent/DAKO-Z5116, , Santa Clara, CA, USA)
was assessed in human- and mouse-specific GI regions.
Immunohistochemistry process. Tissue was fixed in 4%
paraformaldehyde, 10 μm sections and whole mounts
were prepared, blocked in universal blocking serum
(Dako, Carpinteria, CA, USA) and incubated overnight at
4°C with primary antibodies. Slides/whole mount tissue
was then incubated for 1 h at room temperature with
AlexaFluor conjugated secondary antibody as appropriate.
Slides/wholemounts were thenmounted using a coverslip
and Vectashield Hardset Mountant conjugated with DAPI
(H-1500) and left to dry before viewing under the micro-
scope at 40×.
Motility studies
Colonic motility in mice was determined using a
multilumen perfusionmanometry apparatus (Fraser et al.
1997). Spontaneous pressure waves were recorded, and
nitric oxide synthase inhibitor [N-ω-nitro-L-arginine
(NOLA), 100 μM) and bile acid (deoxycholic acid,
100 μM) induced effects on motility were assessed.
Separate experiments with prucalopride (3 μM) addition
were performed in each mouse group, and similarly
various motility parameters were assessed. Recordings
were obtained and analysed manually using medical
measurement system (MMS) software.
Pellet output
Mice were housed overnight in individual cages with a
wire bottom to collect faecal pellets over 6 days. The total
number of pellets was counted and weighed daily.
Ussing chamber studies
Submucosal–mucosal sheetswere isolated andmounted in
Ussing chambers (exposed area of 0.14 cm2) continuously
bathed in Krebs-Henseleit buffer as described previously
(Hyland et al. 2003). The mucosae were voltage clamped
at 0 mV (DVC 1000, World Precision Instruments,
Stevenage, UK) and short-circuit current (ISc) was
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recorded continuously. Veratridine (which depolarizes the
intact submucosal innervation of the mucosa and causes
epithelial anion secretion) was added at 30 μM to each
serosal hemi-chamber and changes in ion transport were
measured. Data were acquired using a 1401 and Spike2
software (Cambridge Electronic Design, Cambridge, UK).
Colonic afferent recording studies
The distal colons from WT and TNX-KO mice were
removed with associated lumbar splanchnic nerves and
activity was recorded using previously described methods
(Hockley et al. 2017).Once a stable recordingwas achieved
(approx. 20 min), a ramp distension was performed by
blocking luminal perfusion out-flow of the cannulated
colon producing noxious pressures known to both evoke
pain behaviours in vivo in mice and robustly activate all
known afferent mechanoreceptors (0–80 mmHg). After
10 min, four successive rapid phasic ramp distensions
(0–80 mmHg, 60 s at 9 min intervals) were performed
by switching luminal perfusion outflow of the cannulated
colon to an 80 mmHg end pressure. The tissue was super-
fused with carbogenated (95% O2, 5% CO2) Krebs buffer
(6 ml/min; 32–34°C; pH 7.4; 124 mM NaCl, 4.8 mM KCl,
1.3 mM NaH2PO4, 1.2 mM MgSO4.7H2O, 2.5 mM CaCl2,
11.1 mM glucose, 25.0 mM NaHCO3). Compliance was
measuredwhich is the total time it takes to reach 80mmHg
intraluminal pressure from the moment the outflow is
closed, multiplied by the rate of intraluminal perfusion
(0.1 ml/min). Data were analysed using Spike 2 software.
Patient genotyping
Eleven patients (three males and eight females) identified
from Radboud University Medical Centre took part and
were genotyped for TNXB (Schalkwijk et al. 2001).
Mutation analysis was performed using next-generation
sequencing (NGS) testing for theTNXBDNAmutation, as
previously described (Demirdas et al. 2016). Additionally,
serum samples were analysed for TNX glycoprotein using
ELISA with rabbit anti-TNX.
GI symptom questionnaire
Patients with TNXdeficiency completed a Flemish version
of the validated Gastrointestinal Symptom Rating Scale
(GSRS) (Svedlund et al. 1988). Questionnaire responses
were translated and scored for five different domains
– reflux, abdominal pain, constipation, indigestion and
diarrhoea. Scores ranged from 1 (no symptoms) to 7
(unbearable symptoms). GSRS scores for abdominal pain
and lower GI symptoms for constipation and diarrhoea
were analysed in TNX-deficient patients compared to
a reference Swedish population of similar age and sex
(Dimenas et al. 1996).
Experimental design and statistical analysis
Immunohistochemistry. Quantitative assessment of
immunohistochemistry images were taken from n = 9
WT vs. n= 9 KO (five females and four males in both
groups) of which five fields of view were captured from
each mouse. Therefore 45 images per neuronal marker
with TNX were then analysed. To determine whether a
neuron is positive we used an approximate threshold of
20% above background. The background was defined
as 0% which was black, while the brightest area in the
image was 100%. Additionally, two blinded researchers
completed the neuronal counts according to the criteria
mentioned. Controls with no primary antibody were
performed with each run of immunohistochemistry to
confirm the specificity of the primary antibody, which
resulted in no fluorescence above background. Western
blot with this antibody in humans revealed a band at
the predicted weight of 268 kDa. Moreover, TNX was
absent from all TNX-KO gut tissue. Images were obtained
using Metamorph software on an Olympus MM Leica
(sections) or Zen software on a Zeiss LSM 710 or Zeiss
LSM 880 (confocal imaging whole-mounts) at 40×
magnification. Statistical analysis was performed using an
unpaired t-test for each marker and a P-value of < 0.05
was deemed significant.
Colonic motility. A total of 11 WT and 11 KO mice (six
females and five males in both groups) were used to
measure spontaneous contractile activity of the colon.
Experiments using NOLA and bile acid–deoxycholic acid
were completed separately; n = 8 WT vs. n = 9 KO mice
(four females and four males in WT and five females and
fourmales in KO group) forNOLA experiments and n= 5
WT vs. n= 5KOmice (three females and twomales in both
groups) for bile acid experiments. Pellet output studies
used n = 9 WT vs. n = 9 KO mice (five females and four
males in both groups) over 6 days and pellets were counted
daily. Separate prucalopride experiments in n = 6 WT vs.
n=6KOmice (four females and twomales inbothgroups)
were also performed. Data from all motility studies were
statistically analysed with an unpaired t-test to compare
each colonic region. For pellet output studies significance
was calculated using an unpaired t-test. Individual data
were plotted for all data sets and a P-value of < 0.05 was
deemed significant.
Colonic secretion. A total of n= 11WT vs. n= 9 KOmice
(six females andfivemales inWTandfive females and four
males in KO) were used. Statistical analysis was performed
with an unpaired t-test to compare each colonic region in
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both groups. All individual datawere plotted and aP-value
of < 0.05 was deemed significant.
Colonic afferent recording. A total of n = 3 WT vs.
n = 3 KO mice (three females in both groups) were used.
Statistical analysis was performed using an unpaired t-test.
Individual data were plotted and a P-value of < 0.05 was
deemed significant.
Patient questionnaires. Eleven patients (three males and
eight females) with TNX deficiency were used and
compared to a reference Swedish population of n = 2162.
The reason for the small sample size in the TNX-deficient
group was due to a small number of patients known to
have TNX deficiency since it is uncommonly measured.
Questionnaire data are shown as mean values with
standard deviation. Statistical analysis was performed
using an unpaired Student’s t-test for each symptom
(P < 0.05).
All data are expressed as individual data points and
variability within the data was represented using 95%
confidence intervals of the mean. Statistical analysis was
performed using GraphPad Prism (v.7.02, GraphPad
Software, Inc., La Jolla, CA, USA).
Results
TNX localization in mouse and human GI tract
TNX-immunoreactivity (IR) inmouse distal (Fig. 1A) and
human descending colon (Fig. 1B) was found specifically
within myenteric and submucous plexus neurones and
not within connective tissue. Neuronal counts within the
mouse submucous and myenteric plexuses revealed that
TNX-IR extensively co-localized with calretinin-IR, and
ChAT-IR (markers for excitatory enteric motorneurones)
(Mazzuoli & Schemann, 2012), but only in a few NOS-IR
(inhibitory) enteric neurones (Fig. 1E) in bothmouse and
human colon. The nociceptive afferent marker CGRP-
(Sharrad et al. 2015) and TNX-IR were in close apposition
in mouse (Fig. 1A) and human colon (Fig. 1B), but
not directly co-localized. CGRP-positive nerve fibres
surrounded myenteric ganglia but did not project within
ganglia containing TNX-IR neuronal cell bodies (Fig. 1A
and B). CGRP-IR was lowest in neuronal counts of cell
bodies co-labellingwithTNX(Fig. 1C andE).Quantitative
polymerase chain reaction (qPCR) analysis showed TNX
was present at the RNA level in mouse colon (data not
shown).
The location of TNX, revealed by confocal optical
sections, suggested that it was intracellular within neuro-
nal cell bodies (Fig. 1). TNX expression was found to
partially overlap with calretinin, an intracellular marker
(Fig. 1A). TNX-IRwas absent from themucosa of all tissue
in mouse (Fig. 1C) and human gut (data not shown).
Importantly, in TNX-KO distal colon, calretinin-IR
myenteric neurones were still observed, but with no TNX
staining as expected, confirming the specificity of the anti-
body (Fig. 1D). In addition, unlikeTNX, tenascinC(TNC)
was not found in enteric neurones and was instead found
in muscle layers and connective tissue within the colon
(data not shown).
Spontaneous colonic migrating motility in mice
The localization of TNX in enteric plexuses strongly
suggested a role in neural control of motility and
secretion. We investigated this by determining the
disruption in bowel function of TNX-deficient mice,
in which we studied complex neural control of colonic
motor function in vitro. The rate and amplitude of
spontaneous pressure waves were significantly reduced
in TNX-KO mice compared to WT, particularly in the
distal colonic segments (Fig. 2A), and therefore the
strength of contractions was weakest in these regions
(Fig. 2C). Peak type differentiation analysis showed a
reduction in single peaks but not double or multiple
peaks (Fig. 2D). The addition of the neuronal prokinetic
5-HT4 receptor ligand prucalopride (3 μM) rescued the
impaired motility by increasing the number of contra-
ctions in the mid-proximal, mid-distal and distal colon
of TNX-KO mice but showed no changes in WT mice
(Fig. 3D and E). Analysis of colonic migrating motor
complexes (CMMCs) showed no difference in CMMC
direction (Fig. 3A), frequency (Fig. 3B) or propagation
velocity (Fig. 3C) between WT and TNX-KO. The effect
of NOS inhibition with NOLA (Brierley et al. 2001) and
activation of neural inhibition viaTGR5using deoxycholic
acid (Bunnett, 2014) was similar in both genotypes (data
not shown). NOS inhibitors and deoxycholic acid were
used to test the role of TNX in inhibitory pathways to
smooth muscle because NOS and TGR5 are involved in
the NO releasing pathways involved in inhibiting colonic
contractility.
Internal rectal intussusception and faecal output in
mice
Based on our observations of disordered motility in
TNX-deficient mice, it would follow that disruption of
bowel habit would also occur in vivo, so we investigated
if the loss of TNX affects defecatory function. In
total, 12% of 38 TNX-KO mice had an internal rectal
intussusception (defined as a partial eversion of a region
of the bowel), whereas WT had none (Fig. 2E). Overall
faecal pellet output decreased significantly in TNX-KO
mice, particularly on day 1 (P < 0.001), but there was no
change in pellet weight (Fig. 2F).
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Figure 1. TNX expression in mouse and human neural structures
Representative immunohistochemical images taken from whole mounts and sections of WT mouse (A) and human
distal colon (B). TNX-IR was commonly expressed in calretinin-positive neurones in the mouse myenteric plexus (MP)
(A-merge) and human submucous plexus (SP) (B-Merge), while TNX- and NOS-positive cells in the MP showed few
co-labelled cell bodies in both mouse and human colon (A and B-Merge). TNX-IR and CGRP expression is mutually
exclusive but in close apposition whereby CGRP-positive fibres surround TNX-positive myenteric neurones in mouse
and human colon (A and B-Merge). TNX specificity is confirmed by the absence of TNX in TNX-KO mouse colon
while calretinin-positive neurones are present in the submucous plexus (C). TNX was not found in the mucosa while
calretinin fibres are present (C). D, average number of neuronal cell bodies per field of view (fov) that co-labelled
TNX plus calretinin/CGRP/NOS and ChAT in SP and MP in mouse and human colon respectively. TNX co-expressed
significantly more with calretinin (55.5%) and ChAT (51.6%) than NOS in mouse MP neurones, with none in SP
and only one neuron in MP. In human colon TNX-IR co-expressed significantly more with ChAT in the MP (100%)
and SP (52.58) than NOS (D). CGRP did not co-label with any TNX-IR cell bodies in the SP and only one in MP in
mouse and human (D). Images on the first three panels (A) were obtained on a confocal microscope and were
taken from a compressed optical slice in a z stack. All other images were obtained from sections. Data shown as
percentages of total neurons positive for TNX and respective markers. Statistical analysis was performed using an
unpaired Student’s t-test for each region, P < 0.05. Scale bar in all panels = 50 μm.
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Figure 2. Colonic motility and pellet output in WT vs. TNX-KO mice
Manometry studies showed a reduction in the number and amplitude of spontaneous pressure waves in TNX-KO
mice (A) (n = 11 WT vs. n = 11 KO). The number of peaks/min was significantly reduced in the mid-proximal
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(P = 0.0475), mid-distal (P = 0.0482) and distal colon (P = 0.0031) (B) and amplitude of pressure waves was
significantly reduced in the mid-distal (P = 0.0069) and distal colon only (P = 0.021) in TNX-KO mice (C). The total
number of spontaneous single peaks over 30 min showed a significant reduction in all colonic regions of TNX-KO
mice except for the proximal colon (D). There was significant change in the number of double and multi-peaks in
all colonic regions in WT vs. KO mice (D). WT colon and rectum were normal whereas in the TNX-KO the rectum
shows intussusception, as indicated by arrow (E). This was observed in 12% of 38 TNX-KO mice. The number
of faecal pellets per day showed a significant decrease in TNX-KO mice (P = 0.0002) although there was no
significant change in pellet weight (F) (n = 9 WT vs. n = 9 KO). Data are shown as individual values with standard
deviation. Statistical analysis was performed using an unpaired Student’s t test for each region, P < 0.05.
Neurally evoked secretory responses in mouse colon
As described earlier, TNX localization in submucous
neurones suggested a role in neural control of mucosal
ion transport. This was measured as changes in ISc after
addition of the neuronal depolarizing agent veratridine,
which induces rapid, sustained increases in ISc by
activating neuronal sodium channels (Hyland & Cox,
2005). There were no significant differences in complex
time-dependent changes in ISc between WT and KO in
any colonic region following veratridine (Fig. 4A and B).
The secondary analysis involved measuring initial peak
ISc within the first minute, a secondary ISc decrease after
initial peak within 2 min and a tertiary peak ISc within the
first 10 min of exposure to veratridine, which showed
no significant differences between WT and TNX-KO
(Fig. 4C).
Finally, the number of monophasic (increase above
baseline), biphasic (decrease below baseline followed by
an increase above baseline) and triphasic ISc responses
(initial increase above the baseline, followed by a decrease
below baseline, finishing with the overall maximum peak)
were analysed following veratridine. The overall number
of veratridine response phases in TNX-KO increased
significantly (P < 0.0001) in particular, mid-distal colon
(P = 0.0005), indicating subtle differences in neural
influences on mucosal ion transport in this region
(Fig. 4D).
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Figure 3. CMMCs and the effect of prucalopride
Detailed analysis on the finer control of the colon, for example in colonic migrating motor complexes (CMMCs),
showing that CMMC direction (A), frequency (B) and propagation velocity (C) did not change in either group.
Addition of 3μM prucalopride (Pru) significantly increased the number of peaks in TNX-KOmid-proximal, mid-distal
and distal colon (P = 0.0031, P < 0.0001 and P < 0.0001, respectively) (D) (n = 6 WT vs. n = 6 KO). The amplitude
of contractions was also restored by the addition of prucalopride in the mid-distal (P = 0.0262) and distal colon
(P = 0.0007) (E). Data are shown as individual values with standard deviation. Statistical analysis was performed
using an unpaired Student’s t test for each region (P < 0.05).
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Sensory fibre density in TNX-KO colonic mucosa
There was no co-expression of the nociceptor marker
CGRPwithTNX, indicatingnodirect involvement inperi-
pheral nociception.However, we noticed upon anatomical
examination of these fibres that there was a threefold
increase in CGRP-IR nerve endings in the colonic mucosa
of TNX-KO mice (Fig. 5A and E) and a smaller increase
in PGP-IR endings (Fig. 5C and E). No changes were
observed for either marker in endings surrounding the
myenteric plexus (Fig. 5B, D and F). Therefore, there is a
proliferation predominantly of nociceptive nerve fibres in
TNX-KO mucosa.
Colonic afferent sensitivity in mice
The sprouting of CGRP-positive fibres in TNX-KO mice
suggested a change in afferent function. Therefore, we
investigated if there was an alteration in mechanosensory
and electrophysiological properties of colonic afferents
that lack TNX. Baseline splanchnic afferent nerve activity
was significantly increased in TNX-KOmice (P= 0.0069)
(Fig. 6A). Phasic responses to distension showed an over-
all significant increase in TNX-KO compared to WT
(P = 0.0206). However, no change in colonic compliance
was observed (Fig. 6D), suggesting increased afferent
sensitivity in TNX-KO is a property of the endings, not
their environment.
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Figure 4. Colonic mucosal ion transport responses in WT and TNX-KO mice
Representative traces showing responses to veratridine in designated colonic tissues fromWT vs. TNX-KO mice (A).
At 20 min veratridine was added and changes in ISc were recorded for 90 min. No difference in veratridine-induced
responses was seen in the colonic regions of WT and TNX-KO mice (B). Overall colonic response to veratridine also
showed no change at initial peak (over 1 min, i.e. primary), second dip (within 2 min, i.e. secondary) or tertiary peak
(10 min) (C). The number of mice with triphasic (i.e. an initial peak, followed by a drop below baseline followed
by an overall increase in secretion) responses to veratridine was significantly increased in KO colon compared to
WT in the mid-distal colon (P = 0.0194) (D) (n = 11 WT vs. n = 9 KO). Data are shown as individual values with
standard deviation. Statistical analysis was performed using an unpaired Student’s t test for each region (P < 0.05).
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Gastrointestinal symptoms in TNX-deficient patients
The evidence presented above indicates an important
role of TNX in the neural control of the mouse gut,
and similar patterns of expression in mouse and human.
We were fortunate to be able to access a cohort of
genetically confirmedTNX-deficient patients, inwhichwe
investigated its role further. In these patients abdominal
pain was increased by 65% compared to controls
(P < 0.0001). Bowel dysfunctions including constipation
(32%, P < 0.05) and diarrhoea (64%, P < 0.0001) were
also increased (Fig. 7). Three of 11 (27%) TNX-deficient
patients assessed in this study reported external rectal
prolapse, which is often associated with constipation.
Discussion
We report TNX is required for neural control of the
bowel by a specific subtype of mainly cholinergic enteric
neurones, adding to its structural role in somatic
connective tissue (Egging et al. 2006). TNX also regulates
sprouting and sensitivity of nociceptive sensory end-
ings in mouse colon. These findings correlate with
symptoms shown by patients and TNX-deficient mice.
Our anatomical and physiological data indicate TNX
is important in neural control of colonic sensory and
motor function. In mouse and human, we found TNX-IR
exclusively with neuronal structures withinmyenteric and
submucous plexuses. TNX-KO mice lacked expression of
TNX as expected, but had altered sensory innervation,
whereby sprouting of CGRP-IR fibres was observed,
indicating an indirect role for TNX in mucosal neural
innervation. TNX-KO mice had disordered colonic
motility and this deficit could be restored by increasing
cholinergic drive with a 5-HT4 receptor agonist. However,
neural control of colonic ion transport was altered
only subtly, indicating a specialized role. TNX-KO
mice have increased sensitivity of colonic afferents to
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Figure 5. Neuronal sprouting in TNX-KO mucosa
Representative immunohistochemical images taken from sections of WT mouse colonic mucosa (A, C) and
myenteric plexus (B, D). CGRP-IR is shown in green (A) where there was a threefold proliferation of CGRP-IR
nerve endings in the colonic mucosa of TNX-KO mice (P < 0.0001) (E). This was also observed with PGP9.5 in red
(C), although this increase was smaller for PGP-IR endings (P = 0.0224) (E). No changes were seen in either marker
in the myenteric plexus (P = 0.3950, P = 0.1368) (F). Data are shown as individual values with standard deviation.
Statistical analysis was performed using an unpaired Student’s t test (P < 0.05). Scale bar in all panels = 20 μm.
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noxious distension, probably following from sprouting
observed anatomically. In principle, the site of localization
corresponds to the site of functional loss that occurs when
TNX is deleted.
We expected TNX would be found in association with
extracellular collagen fibrils in connective tissue as in
mouse skin (Bristow et al. 2005). Indeed, TNX was
found in dermis (Egging et al. 2006). However, in the
GI tract, TNX was exclusively expressed in neuronal
somata. In mouse and human colon, TNX associated pre-
dominantly with ChAT- and calretinin-expressing neuro-
nes in submucous and myenteric plexuses, with less
labelling in NOS-positive neurones. This pattern of TNX
expression suggests that it has a preferential role in
excitatory pathways of smooth muscle and epithelial cells.
TNX-antibody specificity in neurones was confirmed in
TNX-KO mice where labelling was absent. Furthermore
TNC was not expressed in neurones but in the connective
tissue within colonic smooth muscle. Thus, TNX may
play a different role in the gut compared with other
tissues – that of a neuronal ECM molecule. Certainly,
other tenascins, R and C, are produced by CNS neurones,
where they contribute to synaptic plasticity at the synaptic
bouton (Kwok et al. 2011). In particular, TNR forms a
specialized ECM microenvironment called peri-neuronal
nets (PNNs) (Kwok et al. 2011). PNNs surround neuro-
nes and dendrites in a mesh-like structure with gaps
at synaptic contacts (Celio & Blumcke, 1994) and are
involved in synaptic plasticity (Kwok et al. 2012). Itmay be
that TNX provides a similar mesh in the enteric nervous
system (ENS). However, further expression studies with
a range of ECM molecules, such as chondroitin-sulfate
proteoglycans commonly found within PNN structures,
are necessary to confirm if an ‘enteric PNN’-like structure
exists.
In light of the expression data, we hypothesized that
TNX-KO mice would have a functional deficit within
the cholinergic pathway mediating motility. Indeed, TNX
deletion caused a significant reduction in the occurrence
of spontaneous pressure waves that was most apparent in
the distal colon. However, the coordination of contra-
ctions showed no overt change, which may signify a
role in the final cholinergic motorneurones rather than
the integrative interneurones, which are more likely
to coordinate the organization/migration of CMMC
throughout the colon (Spencer & Bywater, 2002). This
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Figure 6. Increased colonic afferent sensitivity in TNX-KO distal colon
Nerve activity from colonic afferent units innervating the distal colon in WT vs. TNX-KO. Nerve activity displayed
by spike frequency (Hz) and raw trace (mV) in WT vs. TNX-KO (A). Baseline splanchnic nerve activity is significantly
increased in TNX- KO (B) (P = 0.0069) as well as average peak firing rate during distension (C) (P = 0.0384) without
changes in colonic compliance (D) (n = 3 WT vs. n = 3 KO). Data are shown as individual values with standard
deviation. Statistical analysis was performed using an unpaired Student’s t test (P < 0.05).
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Figure 7. Gastrointestinal symptoms in TNX-deficient patients
and healthy controls
The severity of gastrointestinal symptoms assessed as gastrointestinal
symptom rating scale (GSRS) scores (means and 95% confidence
interval) in patients with TNX deficiency (n = 11) and healthy
controls (n = 2162). Abdominal pain, constipation and diarrhoea
were significantly higher compared to Swedish controls
(∗∗∗∗P < 0.0001, ∗∗∗P = 0.0194). Data are shown as mean values
with standard deviation. Statistical analysis was performed using an
unpaired Student’s t test for each symptom (P < 0.05).
concept is shown schematically in Fig. 8, where defective
anti-adhesive properties in TNX deficiency are hypo-
thesized to lead to reduced neurotransmission. NOS
inhibition had similar effects in WT and TNX-KO, as
did activation of TGR5 with bile salt indicating TNX
has little role in inhibitory pathways to smooth muscle.
Cholinergic blockade within the ganglion or at the neuro-
muscular junction both abolish CMMC (Brierley et al.
2001), so it was not possible to test pharmacologically the
extent of the cholinergic deficit. The selective 5HT4 agonist
prucalopride (Briejer et al. 2001) restored the impaired
motility observed in TNX-KO distal colon, an action
known to be via increased cholinergic output (Leclere
et al. 2005). Further studies are required to elucidate the
mechanisms bywhichmotility is specifically increased and
the role of 5HT4. Of importance in vitro studies may not
entirely reflect the natural state of the colon thus further
in vivo studies will confirm whether impaired motility
persists in TNX-KO mice and indeed whether this can be
rescued.
Reduction of distal colonic motility impairs both
evacuatory function and colonic pellet-forming motility,
which we observed as reduced faecal output in
TNX-KO mice. Patients with TNX deficiency also
demonstrated lower gut symptoms with significantly
increased constipation and diarrhoea. Combined reports
of constipation and diarrhoea could be due to a secondary
problem in TNX-deficient patients who start with severe
constipation that often leads to bacterial overgrowth
leading to reactive diarrhoea (Lokiec et al. 2014). Many
patients in this study reported both diarrhoea and
constipation, and thus have alternating bowel habits.
TNX-deficient patients assessed in this study pre-
viously reported external rectal prolapse (Demirdas et al.
2016). Additionally, a history of rectal prolapse was most
common in the hEDS subgroup compared to other
EDS subtypes (Nelson et al. 2015). Similarity between
human and mouse phenotype is clear, as TNX-deficient
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Figure 8. Hypothesized anti-adhesive mechanisms by which TNX supports the motor function
In the colon, TNX acts to maintain correct orientation and spacing of synaptic contacts at neuronal and neuro-
muscular junctions. Thus, the release of neurotransmitter is able to reach the postsynaptic receptor and engage
effectively with it, giving rise to an optimal contractile response to neural activation. Without TNX, these junctions
are disorganized, possibly by being too narrow, and fail to allow efficient neurotransmission.
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mice also had internal rectal intussusception. Importantly,
intussusception and prolapse are a logical consequence of
inadequate control of lower GI smooth muscle.
A role of TNX in neural control of ion transport was
suggested by its abundance in submucous neurones, many
of which innervate epithelial cells. Activation of intrinsic
enteric neurones to the mucosa releases non-cholinergic
transmitters, e.g. vasoactive intestinal peptide (VIP) and
to a lesser degree ACh. These increase ISc which reflects
epithelial secretion of chloride and fluid. There was no
difference in basal or veratridine-stimulated ISc between
WT and TNX-KO colon. There was, however, a tendency
for the pattern and time course of response to shift towards
more triphases in ISc during the response. We may have
expected, like the motility results, reduced cholinergic
secretory responses, especially given the preponderance
of TNX in submucous cholinergic neurones. However,
VIP-containing secretomotor neurones account for 80%
of all submucosal neurones in the mouse colon (Foong
et al. 2014), so the contribution of ChAT-containing
cholinergic neurones towards neural regulation of colonic
secretion is relatively small (as borne out by these and
previous studies) (Hyland & Cox, 2005). Thus, the
complex mucosal ISc responses in colonic tissues from
TNX-deficient mice are less likely to be affected, but there
may be subtle changes in responses to nerve activation. To
delineate if TNX has any role in barrier function, further
studies are required, for example on the expression of
tight junction proteins in the TNX-KO mouse as well as
permeability assessments.
The significant increase in PGP9.5-IR neuronal endings
in theTNX-KOcolonicmucosa is probablydue to a change
in sensory innervation evidenced by a larger increase in
CGRP-IR, a marker for nociceptive afferents (Robinson
et al. 2004). Thus, in the absence of TNX, there is a change
in innervation that may result in increased sensitivity to
pain. This may be due to the anti-adhesive properties of
TNX (Valcourt et al. 2015). TNX induces a loss of adhesion
through the p38 mitogen protein-activated kinase (MAP)
pathway, which is required for cell detachment (Rosen
et al. 2002). Similarly, TNX in the ENS may be involved
in signalling pathways that repel sensory endings from
invading the colonic mucosa. Indeed, ECM glycoprotein
tenascin/J1 or janusin, which shares structural homology
with TNX, acts as a barrier for neurite outgrowth in the
CNS (Schachner et al. 1994).
In human studies, increased nerve fibre outgrowth
measured by neuron-specific enolase (a general neuronal
marker) in colonic mucosa of irritable bowel syndrome
patients has been reported (Yu et al. 2012; Dothel et al.
2015). Of importance, expression of transient receptor
potential vanilloid type-1 (TRPV1) involved in mediating
pain was increased in IBS patients which correlated with
increased abdominal pain scores (Akbar et al. 2008).
Specifically, a 3.5-fold increase in TRPV1 was reported
(Akbar et al. 2008) similar to the 3-fold increase in
CGRP observed in the TNX-KO mucosa. This suggests
that similar to IBS patients who have increased visceral
pain and increased nociceptive nerves, TNX-KO mice
may also have visceral hypersensitivity. We observed
this in an increased sensitivity of high-threshold colonic
afferents at rest and during phasic distensions in TNX-KO
mice. Other changes are possible, including changes to
ion channel phenotype in sensory nerves that promote
afferent depolarization (Jones et al. 2005; Yiangou et al.
2007). Increased nociceptive endings and hypersensitive
afferents in TNX-KO mice correlate with increased
abdominal pain in TNX-deficient patients reported in
this study and in hEDS patients (Fikree et al. 2014) that
is likely to constitute the increase in visceral pain. Of
significance, molecules within the ECM interact with the
β subunit of the voltage-gated sodium channels (Nav)
(Fuentes & Christianson, 2016) that regulate excitability
of sensory neurones by reducing the activation threshold
(de Carvalho Rocha et al. 2014). Further expression
studies of TRP channels and voltage-gated ion channels,
for example Nav, would elucidate the role of TNX in
visceral pain pathways. The oestrus cycle has potent effects
on nociceptive pathways. Whether the differences we
observed are complicated by altered endocrine function
requires further study using male mice.
Tenascins were once labelled ‘talented proteins in search
of function’ (Hsia & Schwarzbauer, 2005). Since then
research has shown multiple roles for various tenascins.
Our data identify the localization of TNX and its
importance in colon, so we can relabel this molecule as
a talented protein with at least two functions in the ENS.
Of importance, our studies set the basis for exploring the
precise mechanisms by which TNX modulates neuronal
behaviour and function, which will set a framework for
further investigations aimed at deciphering the role of
ECM in gastrointestinal function and disease. Moreover,
TNX genotype should be evaluated routinely in hEDS
patients to better understand its role in specific symptoms,
and thus allow targeted treatment of colonicmotility (Lacy
et al. 2009) and abdominal nociception (Lyubashina et al.
2015).
References
Akbar A, Yiangou Y, Facer P, Walters JR, Anand P & Ghosh S
(2008). Increased capsaicin receptor TRPV1-expressing
sensory fibres in irritable bowel syndrome and their
correlation with abdominal pain. Gut 57, 923–929.
Briejer MR, Bosmans JP, Van Daele P, Jurzak M, Heylen L,
Leysen JE, Prins NH & Schuurkes JA (2001). The in vitro
pharmacological profile of prucalopride, a novel
enterokinetic compound. Eur J Pharmacol 423, 71–83.
Brierley SM, Nichols K, Grasby DJ & Waterman SA (2001).
Neural mechanisms underlying migrating motor complex
C© 2018 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
14 R. Aktar and others J Physiol 0.0
formation in mouse isolated colon. Br J Pharmacol 132,
507–517.
Bristow J, Carey W, Egging D & Schalkwijk J (2005).
Tenascin-X, collagen, elastin, and the Ehlers-Danlos
syndrome. Am J Med Genet C Semin Med Genet 139C, 24–30.
Bunnett NW (2014). Neuro-humoral signalling by bile acids
and the TGR5 receptor in the gastrointestinal tract. J Physiol
592, 2943–2950.
Burch GH, Gong Y, Liu W, Dettman RW, Curry CJ, Smith L,
Miller WL & Bristow J (1997). Tenascin-X deficiency is
associated with Ehlers-Danlos syndrome. Nat Genet 17,
104–108.
Celio MR & Blumcke I (1994). Perineuronal nets–a specialized
form of extracellular matrix in the adult nervous system.
Brain Res Brain Res Rev 19, 128–145.
Cox HM, Pollock EL, Tough IR & Herzog H (2001). Multiple Y
receptors mediate pancreatic polypeptide responses in
mouse colon mucosa. Peptides 22, 445–452.
de Carvalho Rocha HA, Dantas BP, Rolim TL, Costa BA & de
Medeiros AC (2014). Main ion channels and receptors
associated with visceral hypersensitivity in irritable bowel
syndrome. Ann Gastroenterol 27, 200–206.
Demirdas S, Dulfer E, Robert L, Kempers M, van Beek D,
Micha D, van Engelen BG, Hamel B, Schalkwijk J, Loeys B,
Maugeri A & Voermans NC (2016). Recognizing the
tenascin-X deficient type of Ehlers-Danlos syndrome: a
cross-sectional study in 17 patients. Clin Genet 91: 411–425.
Dimenas E, Carlsson G, Glise H, Israelsson B &Wiklund I
(1996). Relevance of norm values as part of the
documentation of quality of life instruments for use in
upper gastrointestinal disease. Scand J Gastroenterol Suppl
221, 8–13.
Dothel G, Barbaro MR, Boudin H, Vasina V, Cremon C,
Gargano L, Bellacosa L, De Giorgio R, Le Berre-Scoul C,
Aubert P, Neunlist M, De Ponti F, Stanghellini V & Barbara
G (2015). Nerve fiber outgrowth is increased in the intestinal
mucosa of patients with irritable bowel syndrome.
Gastroenterology 148, 1002–1011 e1004.
Egging DF, van Vlijmen I, Starcher B, Gijsen Y, Zweers MC,
Blankevoort L, Bristow J & Schalkwijk J (2006). Dermal
connective tissue development in mice: an essential role for
tenascin-X. Cell Tissue Res 323, 465–474.
Fikree A, Aktar R, Grahame R, Hakim AJ, Morris JK, Knowles
CH & Aziz Q (2015). Functional gastrointestinal disorders
are associated with the joint hypermobility syndrome in
secondary care: a case-control study. Neurogastroenterol
Motil 27, 569–579.
Fikree A, Grahame R, Aktar R, Farmer AD, Hakim AJ, Morris
JK, Knowles CH & Aziz Q (2014). A prospective evaluation
of undiagnosed joint hypermobility syndrome in patients
with gastrointestinal symptoms. Clin Gastroenterol Hepatol
12, 1680–1687.e1682.
Foong JP, Tough IR, Cox HM & Bornstein JC (2014).
Properties of cholinergic and non-cholinergic submucosal
neurons along the mouse colon. J Physiol 592, 777–793.
Fraser R, Frisby C, Schirmer M, Blackshaw A, Langman J, Yeoh
E, Rowland R & Horowitz M (1997). Effects of fractionated
abdominal irradiation on small intestinal motility–studies in
a novel in vitro animal model. Acta Oncol 36, 705–710.
Fuentes IM & Christianson JA (2016). Ion channels, ion
channel receptors, and visceral hypersensitivity in irritable
bowel syndrome. Neurogastroenterol Motil 28, 1613–1618.
Geffrotin C, Garrido JJ, Tremet L & Vaiman M (1995). Distinct
tissue distribution in pigs of tenascin-X and tenascin-C
transcripts. Eur J Biochem 231, 83–92.
Grundy D (2015). Principles and standards for reporting
animal experiments in The Journal of Physiology and
Experimental Physiology. J Physiol 593, 2547–2549.
Hakim A & Grahame R (2003). Joint hypermobility. Best Pract
Res Clin Rheumatol 17, 989–1004.
Hockley JR, Gonzalez-Cano R, McMurray S, Tejada-Giraldez
MA, McGuire C, Torres A, Wilbrey AL, Cibert-Goton V,
Nieto FR, Pitcher T, Knowles CH, Baeyens JM, Wood JN,
Winchester WJ, Bulmer DC, Cendan CM &McMurray G
(2017). Visceral and somatic pain modalities reveal NaV
1.7-independent visceral nociceptive pathways. J Physiol 595,
2661–2679.
Hsia HC & Schwarzbauer JE (2005). Meet the tenascins:
multifunctional and mysterious. J Biol Chem 280,
26641–26644.
Hyland NP & Cox HM (2005). The regulation of
veratridine-stimulated electrogenic ion transport in mouse
colon by neuropeptide Y (NPY), Y1 and Y2 receptors. Br J
Pharmacol 146, 712–722.
Hyland NP, Sjoberg F, Tough IR, Herzog H & Cox HM (2003).
Functional consequences of neuropeptide Y Y 2 receptor
knockout and Y2 antagonism in mouse and human colonic
tissues. Br J Pharmacol 139, 863–871.
Jones RC, 3rd, Xu L & Gebhart GF (2005). The
mechanosensitivity of mouse colon afferent fibers and their
sensitization by inflammatory mediators require transient
receptor potential vanilloid 1 and acid-sensing ion channel
3. J Neurosci 25, 10981–10989.
Kwok JC, Dick G, Wang D & Fawcett JW (2011). Extracellular
matrix and perineuronal nets in CNS repair. Dev Neurobiol
71, 1073–1089.
Kwok JC, Warren P & Fawcett JW (2012). Chondroitin sulfate:
a key molecule in the brain matrix. Int J Biochem Cell Biol 44,
582–586.
Lacy BE, Loew B & Crowell MD (2009). Prucalopride for
chronic constipation. Drugs Today (Barc) 45, 843–853.
Leclere PG, Prins NH, Schuurkes JA & Lefebvre RA (2005).
5-HT4 receptors located on cholinergic nerves in human
colon circular muscle. Neurogastroenterol Motil 17, 366–375.
Lindor NM & Bristow J (2005). Tenascin-X deficiency in
autosomal recessive Ehlers-Danlos syndrome. Am J Med
Genet A 135, 75–80.
Lokiec K, Klupinska G, Walecka-Kapica E & Blonska A (2014).
[Estimation of small intestinal bacterial overgrowth in
patients with constipation and diarrhea irritable bowel
syndrome]. Pol Merkur Lekarski 36, 307–310.
Lyubashina OA, Busygina II, Panteleev SS & Nozdrachev AD
(2015). The 5HT4 receptor agonist prucalopride suppresses
abdominal nociception. Dokl Biol Sci 461, 76–79.
Malfait F, Francomano C, Byers P, Belmont J, Berglund B,
Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori
M, Cohen H, Colombi M, Demirdas S, De Backer J, De
Paepe A, Fournel-Gigleux S, Frank M, Ghali N, Giunta C,
C© 2018 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
J Physiol 0.0 The role of tenascin-X in enteric neurones 15
Grahame R, Hakim A, Jeunemaitre X, Johnson D,
Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T,
Lavallee ME, Levy H, Mendoza-Londono R, Pepin M, Pope
FM, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey
GJ, Van Damme T, Vandersteen A, van Mourik C, Voermans
N, Wheeldon N, Zschocke J & Tinkle B (2017). The 2017
international classification of the Ehlers-Danlos syndromes.
Am J Med Genet C Semin Med Genet 175, 8–26.
Mao JR, Taylor G, Dean WB, Wagner DR, Afzal V, Lotz JC,
Rubin EM & Bristow J (2002). Tenascin-X deficiency mimics
Ehlers-Danlos syndrome in mice through alteration of
collagen deposition. Nat Genet 30, 421–425.
Mazzuoli G & Schemann M (2012). Mechanosensitive enteric
neurons in the myenteric plexus of the mouse intestine. PLoS
One 7, e39887.
Nelson AD, Mouchli MA, Valentin N, Deyle D, Pichurin P,
Acosta A & Camilleri M (2015). Ehlers Danlos syndrome
and gastrointestinal manifestations: a 20-year experience at
Mayo Clinic. Neurogastroenterol Motil 27, 1657–1666.
Page AJ, Brierley SM, Martin CM, Martinez-Salgado C,
Wemmie JA, Brennan TJ, Symonds E, Omari T, Lewin GR,
Welsh MJ & Blackshaw LA (2004). The ion channel ASIC1
contributes to visceral but not cutaneous mechanoreceptor
function. Gastroenterology 127, 1739–1747.
Robinson DR, McNaughton PA, Evans ML & Hicks GA (2004).
Characterization of the primary spinal afferent innervation
of the mouse colon using retrograde labelling.
Neurogastroenterol Motil 16, 113–124.
Rosen K, Shi W, Calabretta B & Filmus J (2002). Cell
detachment triggers p38 mitogen-activated protein
kinase-dependent overexpression of Fas ligand. A novel
mechanism of Anoikis of intestinal epithelial cells. J Biol
Chem 277, 46123–46130.
Sarna SK (1993). Colonic motor activity. Surg Clin North Am
73, 1201–1223.
Sarna SK (2010). Colonic Motility: From Bench Side to Bedside.
Morgan & Claypool Life Sciences. San Rafael, CA.
Schachner M, Taylor J, Bartsch U & Pesheva P (1994). The
perplexing multifunctionality of janusin, a tenascin-related
molecule. Perspect Dev Neurobiol 2, 33–41.
Schalkwijk J, Zweers MC, Steijlen PM, Dean WB, Taylor G, van
Vlijmen IM, van Haren B, Miller WL & Bristow J (2001). A
recessive form of the Ehlers-Danlos syndrome caused by
tenascin-X deficiency. N Engl J Med 345, 1167–1175.
Sharrad DF, Hibberd TJ, Kyloh MA, Brookes SJ & Spencer NJ
(2015). Quantitative immunohistochemical co-localization
of TRPV1 and CGRP in varicose axons of the murine
oesophagus, stomach and colorectum. Neurosci Lett 599,
164–171.
Spencer NJ & Bywater RA (2002). Enteric nerve stimulation
evokes a premature colonic migrating motor complex in
mouse. Neurogastroenterol Motil 14, 657–665.
Svedlund J, Sjodin I & Dotevall G (1988). GSRS–a clinical
rating scale for gastrointestinal symptoms in patients with
irritable bowel syndrome and peptic ulcer disease. Dig Dis
Sci 33, 129–134.
Valcourt U, Alcaraz LB, Exposito JY, Lethias C & Bartholin L
(2015). Tenascin-X: beyond the architectural function. Cell
Adh Migr 9, 154–165.
Yiangou Y, Facer P, Chessell IP, Bountra C, Chan C, Fertleman
C, Smith V & Anand P (2007). Voltage-gated ion channel
Nav1.7 innervation in patients with idiopathic rectal
hypersensitivity and paroxysmal extreme pain disorder
(familial rectal pain). Neurosci Lett 427, 77–82.
Yu YB, Zuo XL, Zhao QJ, Chen FX, Yang J, Dong YY, Wang P &
Li YQ (2012). Brain-derived neurotrophic factor contributes
to abdominal pain in irritable bowel syndrome. Gut 61,
685–694.
Zweers MC, Bristow J, Steijlen PM, Dean WB, Hamel BC,
Otero M, Kucharekova M, Boezeman JB & Schalkwijk J
(2003). Haploinsufficiency of TNXB is associated with
hypermobility type of Ehlers-Danlos syndrome. Am J Hum
Genet 73, 214–217.
Additional information
Competing interest
The authors declare no competing financial interests.
Author contributions
All authors had access to the study data and reviewed and
approved the final manuscript. Professor Aziz and Professor
Blackshaw are joint senior authors. Study concept and design-
LAB, QA, RA. Acquisition of data- RA, MP, NCV, PW, VCG.
Analysis and interpretationof data-RA, LAB,MP,VCG.Drafting
of the manuscript- RA. Critical revision of the manuscript for
important intellectual content-LAB, QA RA. Statistical analysis-
RA, MP. Obtained funding- LAB, QA. Administrative, technical
or material support- AF, MW, IRT, VCG, EJA, SDM, JM, SMS,
DB, HJC, NCV, CB. Study supervision- LAB, QA, NCV, EJA.
Funding
This work was funded by a Wellcome Trust University Award
and a Henry Smith Charity Grant to Prof. Blackshaw, a Bowel
andCancer Research PhD studentship toDrAktar, and anEhlers
Danlos Society Award to Prof. Aziz.
Acknowledgements
We would like to thank Professor Charlie Knowles and the
surgical team for providing access to human resection tissue.
This paper is dedicated to the memory of Dr Susan Surguy who
helped in many ways with this research, but passed away before
its publication.
C© 2018 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
